Adverse event monitoring in clinical tri
β
M.-A. Wallander; P. Lundborg; K. SvΓ€rdsudd
π
Article
π
1992
π
Springer
π
English
β 660 KB
Although most clinical trials encompass aspects of safety, methods for assessing the safety of a drug by recording adverse events have been poorly studied. It has been suggested that adverse events rather than adverse drug reactions should be monitored, since a reliable determination of which events